MA26782A1 - Pyrazolobenzodiazepines en tant qu'inhibiteurs de cdk2. - Google Patents

Pyrazolobenzodiazepines en tant qu'inhibiteurs de cdk2.

Info

Publication number
MA26782A1
MA26782A1 MA26368A MA26368A MA26782A1 MA 26782 A1 MA26782 A1 MA 26782A1 MA 26368 A MA26368 A MA 26368A MA 26368 A MA26368 A MA 26368A MA 26782 A1 MA26782 A1 MA 26782A1
Authority
MA
Morocco
Prior art keywords
pyrazolobenzodiazepines
cdk2 inhibitors
cdk2
inhibitors
Prior art date
Application number
MA26368A
Other languages
English (en)
Inventor
Vincent Stewart Madison
Giacomo Pizzo-Lato
Peter Michael Wovkulich
Qingjie Ding
Chung-Chen Wei
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA26782A1 publication Critical patent/MA26782A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/22—Sulfur atoms
MA26368A 1999-04-21 2001-10-19 Pyrazolobenzodiazepines en tant qu'inhibiteurs de cdk2. MA26782A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13037099P 1999-04-21 1999-04-21

Publications (1)

Publication Number Publication Date
MA26782A1 true MA26782A1 (fr) 2004-12-20

Family

ID=22444382

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26368A MA26782A1 (fr) 1999-04-21 2001-10-19 Pyrazolobenzodiazepines en tant qu'inhibiteurs de cdk2.

Country Status (33)

Country Link
US (3) US6440959B1 (fr)
EP (1) EP1185529B1 (fr)
JP (1) JP3746680B2 (fr)
KR (1) KR100481757B1 (fr)
CN (2) CN1279029C (fr)
AR (1) AR023542A1 (fr)
AT (1) ATE279413T1 (fr)
AU (1) AU768667B2 (fr)
BR (1) BR0009887A (fr)
CA (1) CA2367704C (fr)
CO (1) CO5170444A1 (fr)
CZ (1) CZ20013738A3 (fr)
DE (1) DE60014893T2 (fr)
DK (1) DK1185529T3 (fr)
ES (1) ES2228522T3 (fr)
HK (1) HK1046278B (fr)
HR (1) HRP20010742A2 (fr)
HU (1) HUP0300318A3 (fr)
IL (1) IL145764A0 (fr)
JO (1) JO2248B1 (fr)
MA (1) MA26782A1 (fr)
NO (1) NO20015065D0 (fr)
NZ (1) NZ514523A (fr)
PE (1) PE20010054A1 (fr)
PL (1) PL200933B1 (fr)
PT (1) PT1185529E (fr)
RU (1) RU2249593C2 (fr)
SI (1) SI1185529T1 (fr)
TR (1) TR200103016T2 (fr)
TW (1) TW585866B (fr)
WO (1) WO2000064900A1 (fr)
YU (1) YU73101A (fr)
ZA (1) ZA200108016B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2466055A1 (fr) * 2001-11-13 2003-05-22 3-Dimensional Pharmaceuticals, Inc. 1,4-benzodiazepines substituees et leurs utilisations pour le traitement du cancer
FR2847253B1 (fr) * 2002-11-19 2007-05-18 Aventis Pharma Sa Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant
PL378116A1 (pl) * 2003-02-27 2006-03-06 Abbott Laboratories Heterocykliczne inhibitory kinazy
RU2394826C2 (ru) * 2004-10-13 2010-07-20 Ф.Хоффманн-Ля Рош Аг Дизамещенные пиразолобензодиазепины, используемые в качестве ингибиторов cdk2 и ангиогенеза, а также для лечения злокачественных новообразований молочной железы, толстого кишечника, легкого и предстательной железы
JP2009511535A (ja) * 2005-10-14 2009-03-19 エフ．ホフマン−ラ ロシュ アーゲー ５−（２−クロロフェニル）−１，２−ジヒドロ−７−フルオロ−８−メトキシ−３−メチル−ピラゾロ［３，４−ｂ］［１，４］ベンゾジアゼピン
EP2081921B1 (fr) 2006-07-10 2010-09-08 PAION UK Limited Sels de benzodiazépine et leurs formes polymorphes à action brève
KR20100073454A (ko) * 2008-12-23 2010-07-01 국립암센터 트란스글루타미나제 억제제로 사용되는 신규한 피라졸로디아제핀계 화합물, 이의 제조방법 및 이를 포함하는 조성물
EP2305647A1 (fr) 2009-09-18 2011-04-06 PAION UK Limited Procédé de préparation d'ester de méthyle d'acide 3-[(4S)-8-bromo-1-méthyl-6-(2-pyridinyl)-4H-imidazo[1,2-a][1,4]benzodiazépine-4-yl] propionique ou son sulfonate de benzène, et composants utiles dans ce procédé
EP2450039A1 (fr) 2010-11-08 2012-05-09 PAION UK Ltd. Régime de dosage permettant la sédation avec CNS 7056 (Remimazolam)
EA028595B1 (ru) * 2012-02-02 2017-12-29 Сенекс Биотекнолоджи Инк. Селективные ингибиторы cdk8/cdk19 и их применение в качестве противометастатических и химиопрофилактических агентов для лечения рака
CN103288828A (zh) * 2012-02-24 2013-09-11 中国科学院大连化学物理研究所 一种合成手性二氢-6H-吲哚并[2,1-c][1,4]-苯并二氮杂卓的方法
CN103288830A (zh) * 2012-02-24 2013-09-11 中国科学院大连化学物理研究所 一种合成手性二氢-5H-吡咯并[2,1-c][1,4]-苯并二氮杂卓的方法
CN102603743B (zh) * 2012-02-24 2014-05-28 南京天易生物科技有限公司 抗肿瘤的氮杂苯并[f]薁衍生物其制备方法及其用途
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
CN106608877B (zh) * 2015-10-21 2018-11-13 新发药业有限公司 一种依鲁替尼中间体4-氨基-3-（4-苯氧基）苯基-1H-吡唑并[3,4-d]嘧啶的制备方法
EP3535253A1 (fr) * 2016-11-01 2019-09-11 H. Hoffnabb-La Roche Ag 1,3-dihydro -1,4-benzodiazépine-2-thiones pour le traitement de maladies liées au snc
AU2017376353B2 (en) * 2016-12-13 2020-02-06 Transthera Sciences (Nanjing), Inc. Multi-kinase inhibitor compound, and crystal form and use thereof
CN109020980B (zh) * 2017-06-09 2020-11-20 华东师范大学 一类抗肿瘤作用的吡唑并嘧啶二氮*衍生物
US11066404B2 (en) 2018-10-11 2021-07-20 Incyte Corporation Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
US11384083B2 (en) 2019-02-15 2022-07-12 Incyte Corporation Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors
US11472791B2 (en) 2019-03-05 2022-10-18 Incyte Corporation Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors
US11919904B2 (en) 2019-03-29 2024-03-05 Incyte Corporation Sulfonylamide compounds as CDK2 inhibitors
US11447494B2 (en) 2019-05-01 2022-09-20 Incyte Corporation Tricyclic amine compounds as CDK2 inhibitors
US11440914B2 (en) 2019-05-01 2022-09-13 Incyte Corporation Tricyclic amine compounds as CDK2 inhibitors
KR20220064369A (ko) 2019-08-14 2022-05-18 인사이트 코포레이션 Cdk2 저해제로서의 이미다졸릴 피리디미딘일아민 화합물
CA3157681A1 (fr) 2019-10-11 2021-04-15 Incyte Corporation Amines bicycliques utilisees en tant qu'inhibiteurs de cdk2
JP2023525732A (ja) * 2020-05-08 2023-06-19 薬捷安康（南京）科技股▲分▼有限公司 抗腫瘍化合物の合成方法及びその中間体
TW202237585A (zh) 2020-11-27 2022-10-01 瑞士商瑞森製藥公司 Ｃｄｋ抑制劑
WO2022149057A1 (fr) 2021-01-05 2022-07-14 Rhizen Pharmaceuticals Ag Inhibiteurs de cdk
WO2022237765A1 (fr) * 2021-05-10 2022-11-17 药捷安康(南京)科技股份有限公司 Composition pharmaceutique et utilisation d'un inhibiteur ciblant plusieurs kinases
WO2024030399A2 (fr) * 2022-08-02 2024-02-08 Lab1636, Llc Utilisation d'un modulateur allostérique positif de gaba-a pour la réduction de l'hypersensibilité tactile

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251911B1 (en) 1996-10-02 2001-06-26 Novartis Ag Pyrimidine derivatives and processes for the preparation thereof
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers

Also Published As

Publication number Publication date
PE20010054A1 (es) 2001-02-07
US6916923B2 (en) 2005-07-12
CO5170444A1 (es) 2002-06-27
EP1185529B1 (fr) 2004-10-13
TR200103016T2 (tr) 2002-04-22
SI1185529T1 (en) 2005-02-28
HK1046278A1 (en) 2003-01-03
HK1046278B (zh) 2005-08-12
KR100481757B1 (ko) 2005-04-11
JP3746680B2 (ja) 2006-02-15
HRP20010742A2 (en) 2002-12-31
AR023542A1 (es) 2002-09-04
IL145764A0 (en) 2002-07-25
DE60014893T2 (de) 2005-10-13
ZA200108016B (en) 2003-03-26
US6838558B2 (en) 2005-01-04
RU2249593C2 (ru) 2005-04-10
CN1196703C (zh) 2005-04-13
PL354405A1 (en) 2004-01-12
WO2000064900A1 (fr) 2000-11-02
CA2367704C (fr) 2008-06-17
BR0009887A (pt) 2002-01-22
CA2367704A1 (fr) 2000-11-02
PT1185529E (pt) 2005-02-28
AU768667B2 (en) 2003-12-18
US6440959B1 (en) 2002-08-27
DK1185529T3 (da) 2005-02-07
DE60014893D1 (de) 2004-11-18
CZ20013738A3 (cs) 2002-08-14
HUP0300318A3 (en) 2004-11-29
AU4748000A (en) 2000-11-10
YU73101A (sh) 2004-05-12
HUP0300318A2 (hu) 2003-06-28
EP1185529A1 (fr) 2002-03-13
ES2228522T3 (es) 2005-04-16
TW585866B (en) 2004-05-01
US20040198976A1 (en) 2004-10-07
CN1348455A (zh) 2002-05-08
NO20015065L (no) 2001-10-18
NO20015065D0 (no) 2001-10-18
JP2002543081A (ja) 2002-12-17
CN1279029C (zh) 2006-10-11
CN1603314A (zh) 2005-04-06
ATE279413T1 (de) 2004-10-15
US20020183514A1 (en) 2002-12-05
NZ514523A (en) 2003-11-28
JO2248B1 (en) 2004-10-07
KR20010112435A (ko) 2001-12-20
PL200933B1 (pl) 2009-02-27

Similar Documents

Publication Publication Date Title
MA26782A1 (fr) Pyrazolobenzodiazepines en tant qu'inhibiteurs de cdk2.
TR200000520A3 (tr) 4-Fenil-piridin türevleri.
DE60019577D1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
BR9810801B1 (pt) composição lìquida aquosa.
MA25499A1 (fr) Contacteur-disjoncteur.
BR0013417B1 (pt) composiÇço aquosa.
BR0014932B1 (pt) conjunto de retenção.
MA26794A1 (fr) Derives de 5-phenyl-pyrimidine.
MA26849A1 (fr) 4-pyridinyle-n-acyl-l-phenylalanines.
MA26775A1 (fr) Inhibiteurs de metalloproteases dihetero substituees.
ID28483A (id) 2-(3,5-bis-trifluorometil-fenil)-metil-n-(6-morfolin-4-il-4-0-tolil-piridin-3-il)-isobutiramida
ITBO990359A0 (it) Elettromandrino .
MA26793A1 (fr) Derives de 4-phenyl-pyrimidine.
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
DE60029755D1 (de) Congawandschutz.
IT1310915B1 (it) Occhiali.
ITBO990358A0 (it) Elettromandrino .
ES1042496Y (es) "pilona sumible".
ES1044838Y (es) Friegasuelos.
ITSS990004V0 (it) Piramide - ricordo.
IT1317869B1 (it) Doccia.
IT1317829B1 (it) Processo per la preparazione di cefonicid per via enzimatica.
ITMI990856A1 (it) Composizione funghicida.
ITCS990004V0 (it) "termocamin0 c.c.m."
IT1310059B1 (it) Coltivatore di ingombro riducibile.